Omega Diagnostics Group PLC Launches VISITECT® CD4 Point-of-care Test

News   Jun 27, 2012

 
Omega Diagnostics Group PLC Launches VISITECT® CD4 Point-of-care Test
 
 
 

RELATED ARTICLES

Using Epigenetic Signatures and Machine Learning to Improve Diagnosis

News

Unique epigenetic signatures for nine neurodevelopmental disorders have been identified, lending to a better method of diagnosis for disorders with much clinical overlap.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Tweak to Technique Could Bolster Disease Detection

News

A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE